Clinical Trials Directory

Trials / Completed

CompletedNCT01417351

Effects of Vitamin D Supplementation During Pregnancy on Clinical Outcomes and Immune Function

Assessment of Inflammatory Markers and Pregnancy Outcomes in Vitamin D-Supplemented Women at Risk of Vitamin D Deficiency: A Double-Blind, Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
USDA, Western Human Nutrition Research Center · Federal
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Researchers at the USDA Western Human Nutrition Research Center and clinicians at UC Davis Medical Center are currently conducting a study on the effects of vitamin D supplementation during pregnancy on maternal health and immune function. The investigators believe that vitamin D supplementation at levels greater than the current recommendation is beneficial for maternal health during pregnancy. In particular, there is evidence that vitamin D deficiency during pregnancy puts women at greater risk for diseases like pre-eclampsia, which may be due to an imbalance in immune function at the placenta. This randomized, double-blind study is designed to test this hypothesis. Pregnant women who participate in the study receive either 400 IU or 2,000 IU of vitamin D per day for the duration of their pregnancy. The investigators will collect blood at three time points during pregnancy (16-20 weeks, 26-28 weeks, 36 weeks gestation) for analysis of immune function and vitamin D status. The investigators are also collecting data on clinical parameters, such as blood pressure and glucose tolerance.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT400 IU vitamin D3Women in this study arm receive 400 IU of vitamin D3 per day, or what is in a standard prenatal multivitamin. They also receive a placebo study supplement.
DIETARY_SUPPLEMENT2,000 IU Vitamin D3Women in this arm receive 2,000 IU vitamin D per day: 400 IU from a standard prenatal multivitamin plus an additional 1,600 IU vitamin D3 in the study supplement.

Timeline

Start date
2010-08-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2011-08-16
Last updated
2013-07-23

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01417351. Inclusion in this directory is not an endorsement.